|
ADCT
|
ADC Therapeutics SA
|
US
|
NYSE
|
|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
|
ARDS
|
Aridis Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ATNM
|
Actinium Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
|
BDX
|
Becton, Dickinson and Company
|
US
|
NYSE
|
|
BGNE
|
BeiGene, Ltd.
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
BNOX
|
Bionomics Limited
|
US
|
NASDAQ
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
CFRX
|
ContraFect Corporation
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
|
FBRX
|
Forte Biosciences, Inc.
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|